Eyebright Medical Technology (beijing) Co., Ltd. Class ASSE: 688050

Announcement on Vesting Results in the 4th Vesting Period of Reserved Grant Portion under the 2021 Restricted Stock Incentive Plan and Stock Listing

May 30, 2026 · Issued by Eyebright Medical Technology (beijing) Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on Vesting Results in the 4th Vesting Period of Reserved Grant Portion under the 2021 Restricted Stock Incentive Plan and Stock Listing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis

Earlier from Eyebright Medical Technology (beijing) Co., Ltd. Class A

InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in ChinaMay 28
Announcement on Resignation and By-election of Employee DirectorMay 22
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood ConferenceApr 30
Announcement on the Result of Shareholding Reduction Plan for Shareholder and Equity Change Reaching the 5% ScaleApr 28

All Eyebright Medical Technology (beijing) Co., Ltd. Class A news releases